Koura, global leader in medical propellants, is set to showcase its industry-leading products to visitors at the Respiratory Drug Delivery exhibition. The four-day event, which runs from 7th to 10th May 2019 at the Estoril Congress Centre, Lisbon, will welcome thousands of guests from around the world.
As a workshop sponsor and exhibitor, Koura’s team of experts with industry-leading experience will showcase the world’s most widely used medical propellant, Zephex 134a. Relied upon by metered-dose inhaler (MDI) manufacturers, the propellant is present in 70% of the world’s inhalers.
Koura will exhibit its globally available products at Stand 61.
The exhibition will be accessible from:
9.30am-6pm on 8th May
8.30am-6pm on 9th May
8.30am-12.30pm on 10th May
Adam Greenland, Marketing Communications Manager at Koura, said: “We have attended RDD the last few years and it’s always been a great opportunity to meet our customers face-to-face and stay up to date with the latest innovations.”
Koura will also host a workshop entitled “HFA 152a – The Next Chapter in the Story of the MDI?”. The workshop will cover environmental regulations, P152a as an alternative MDI propellant, safety studies, impact on other key MDI components and the P152a MDI production process.
During the workshop, attendees will gain a more in-depth understanding of the implications around the potential introduction of the new HFA propellant on their MDI products. They will also get a glimpse of the exciting and challenging times ahead.
The workshop will take place on 8th May 2019.
To find out more about the event or to register, please visit www.rddonline.com.
To learn more about Koura’s products, visit kouraglobal.com.